Global, regional and country-level 90-90-90 estimates for 2018: assessing progress towards the 2020 target.
Journal
AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219
Informations de publication
Date de publication:
15 12 2019
15 12 2019
Historique:
pubmed:
7
9
2019
medline:
2
10
2020
entrez:
7
9
2019
Statut:
ppublish
Résumé
In 2014, the Joint United Nations Programme on HIV/AIDS (UNAIDS) and partners set the 90-90-90 target for the year 2020: diagnose 90% of all people living with HIV (PLHIV); treat 90% of people who know their status; and suppress the virus in 90% of people on treatment. In 2015, countries began reporting to UNAIDS on progress against 90-90-90 using standard definitions and methods. We used data submitted to UNAIDS from 170 countries to assess country-specific progress towards 90-90-90 through 2018. To assess global and regional progress, overall and by sex for adults aged 15 years and older, we combined country-reported data with estimates generated with a Bayesian hierarchical model. A total of 60 countries reported on all three 90s in 2018, up from 23 in 2015. Among all PLHIV worldwide, 79% (67-92%) knew their HIV status. Of these, 78% (69-82%) were accessing treatment and 86% (72-92%) of people accessing treatment had suppressed viral loads. Of the 37.9 million (32.7-44.0 million) PLHIV worldwide, 53% (43-63%) had suppressed viral loads. The gap to fully achieving 73% of PLHIV with suppressed viral load was 7.7 million; 15 countries had already achieved this target by 2018. Increased data availability has led to improved measures of country and global progress towards the 90-90-90 target. Although gains in access to testing and treatment continue, many countries and regions are unlikely to reach the 90-90-90 target by 2020.
Sections du résumé
BACKGROUND
In 2014, the Joint United Nations Programme on HIV/AIDS (UNAIDS) and partners set the 90-90-90 target for the year 2020: diagnose 90% of all people living with HIV (PLHIV); treat 90% of people who know their status; and suppress the virus in 90% of people on treatment. In 2015, countries began reporting to UNAIDS on progress against 90-90-90 using standard definitions and methods.
METHODS
We used data submitted to UNAIDS from 170 countries to assess country-specific progress towards 90-90-90 through 2018. To assess global and regional progress, overall and by sex for adults aged 15 years and older, we combined country-reported data with estimates generated with a Bayesian hierarchical model.
RESULTS
A total of 60 countries reported on all three 90s in 2018, up from 23 in 2015. Among all PLHIV worldwide, 79% (67-92%) knew their HIV status. Of these, 78% (69-82%) were accessing treatment and 86% (72-92%) of people accessing treatment had suppressed viral loads. Of the 37.9 million (32.7-44.0 million) PLHIV worldwide, 53% (43-63%) had suppressed viral loads. The gap to fully achieving 73% of PLHIV with suppressed viral load was 7.7 million; 15 countries had already achieved this target by 2018.
CONCLUSION
Increased data availability has led to improved measures of country and global progress towards the 90-90-90 target. Although gains in access to testing and treatment continue, many countries and regions are unlikely to reach the 90-90-90 target by 2020.
Identifiants
pubmed: 31490781
doi: 10.1097/QAD.0000000000002355
pmc: PMC6919229
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
S213-S226Subventions
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Références
AIDS. 2009 Jul 17;23(11):1397-404
pubmed: 19381076
AIDS. 2019 Feb 1;33(2):349-352
pubmed: 30557162
AIDS Rev. 2018 Apr-Jun;20(2):83-93
pubmed: 29938702
Lancet HIV. 2016 May;3(5):e221-30
pubmed: 27126489
Lancet HIV. 2018 Aug;5(8):e417-e426
pubmed: 30030134
PLoS Med. 2017 Apr 4;14(4):e1002253
pubmed: 28376085
Oman Med J. 2019 Jan;34(1):1-8
pubmed: 30671177
AIDS Behav. 2018 Aug;22(8):2435-2457
pubmed: 29464430
N Engl J Med. 2019 Jul 18;381(3):219-229
pubmed: 31314966
AIDS Res Ther. 2016 Sep 08;13(1):30
pubmed: 27617024
JMIR Public Health Surveill. 2017 Feb 03;3(1):e8
pubmed: 28159730
BMC Public Health. 2018 Mar 2;18(1):303
pubmed: 29499668
Curr Opin HIV AIDS. 2016 Mar;11 Suppl 1:S1-5
pubmed: 26945141
Curr Opin HIV AIDS. 2012 Mar;7(2):99-105
pubmed: 22227585
Science. 2013 Feb 22;339(6122):966-71
pubmed: 23430656
AIDS Behav. 2018 Mar;22(3):791-799
pubmed: 27990579
JMIR Public Health Surveill. 2018 May 22;4(2):e28
pubmed: 29789279
PLoS Med. 2017 Dec 12;14(12):e1002468
pubmed: 29232366
N Engl J Med. 2019 Jul 18;381(3):207-218
pubmed: 31314965
J Acquir Immune Defic Syndr. 2011 Aug;57 Suppl 2:S61-3
pubmed: 21857297
BMJ Glob Health. 2016 Sep 15;1(2):e000010
pubmed: 28588933
J Int Assoc Provid AIDS Care. 2017 Jan/Feb;16(1):75-80
pubmed: 26518590
AIDS. 2019 Dec 15;33 Suppl 3:S227-S234
pubmed: 31805028
AIDS. 2013 Apr 24;27(7):1159-65
pubmed: 23902921
AIDS. 2019 Dec 15;33 Suppl 3:S203-S211
pubmed: 31343430
PLoS One. 2016 May 09;11(5):e0154893
pubmed: 27159260
Lancet Infect Dis. 2014 Apr;14(4):281-90
pubmed: 24602844
PLoS One. 2018 Sep 19;13(9):e0201352
pubmed: 30231030
AIDS. 2019 Dec 15;33 Suppl 3:S255-S269
pubmed: 31764066
Clin Infect Dis. 2018 May 2;66(10):1487-1491
pubmed: 29324994
N Engl J Med. 2000 Mar 30;342(13):921-9
pubmed: 10738050
J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):28-37
pubmed: 29847474
J Community Health. 2018 Apr;43(2):338-347
pubmed: 28924725
Implement Sci. 2018 May 23;13(1):70
pubmed: 29792230